COVID-19 Convalescents Exhibit Humoral Immunity to SARS-COV-2 Envelope (E) Protein
https://doi.org/10.33647/2074-5982-18-3-32-36
Abstract
In this work, we obtain a producer of the recombinant SARS-CoV-2 E protein and develop a system for its expression and purification in a soluble form. ELISA confirmed its antigenic properties. In COVID-19 convalescents, the level of IgG against the E protein was significantly increased in comparison with the control group of patients.
Supporting agencies: Grant of the FSBSI SC FHHRP “Youth Project of the Year”.
About the Authors
E. A. Orlova
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
Elizaveta A. Orlova.
664003, Irkutsk, Timiryazeva Str., 16.
I. G. Kondratov
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
Ilya G. Kondratov - Cand. Sci. (Biol.), Scientific Centre for Family Health and Human Reproduction Problems.
664003, Irkutsk, Timiryazeva Str., 16.
O. B. Ogarkov
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
Oleg B. Ogarkov - Dr. Sci. (Med.), Scientific Centre for Family Health and Human Reproduction Problems.
664003, Irkutsk, Timiryazeva Str., 16.
References
1. Chang S.E., Feng A., Menget W., Apostolidis S.A., Mack E., Artandi M., Barman L., Bennett K., Chakraborty S., Chang I., Cheung P., Chinthrajah S., Dhingra S., Do E., Finck A., Gaano A., GeBner R., Giannini H.M., Gonzalez J., Greib S., Gundisch M., Hsu A.R., Kuo A., Manohar M., Mao R., Neeli I., Neubauer A., Oniyide O., Powell A.E., Puri R., Renz H., Schapiro J., Weidenbacher P.A., Wittman R., Ahuja N., Chung H.R., Jagannathan P., James J.A., Kim P.S., Meyer N.J., Nadeau K.C., Radic M., Robinson W.H., Singh U., Wang T.T., Wherry E.J., Skevaki C., Luning Prak E.T., Utz P.J. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat. Commun. 2021;12(1):e5417. DOI: 10.1038/s41467-021-25509-3.
2. Madan M., Pahuja S., Mohanet A., Pandey R.M., Madan K., Hadda V., Tiwari P., Guleria R., Mittal S. TB infection and BCG vaccination: Are we protected from COVID-19? Public Health. 2020;185:91-92. DOI: 10.1016/j.puhe.2020.05.042.
3. Netea M.G., Giamarellos-Bourboulis E.J., Dominguez-Andres J., Curtis N., van Crevel R., van de Veerdonk F.L., Bonten M. Trained immunity: A tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell. 2020;181(5):969-977. DOI: 10.1016/j.cell.2020.04.042.
4. Nuovo G., Tili E., Suster D., Matys E., Hupp L., Magro C. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine. Ann. Diagn. Pathol. 2020;48:151600. DOI: 10.1016/j.anndiag-path.2020.151600.
5. Szymczak A., J^druchniewicz N., Torelli A., Kacz-marzyk-Radka A., Coluccio R., Klak M., Konie-czny A., Ferenc S., Witkiewicz W., Montomoli E., Miernikiewicz P, B^chor R., D^browska K. Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples. J. Gen. Virol. 2021;102(11):001692. DOI: 10.1099/JGV.0.001692.
Review
For citations:
Orlova E.A., Kondratov I.G., Ogarkov O.B. COVID-19 Convalescents Exhibit Humoral Immunity to SARS-COV-2 Envelope (E) Protein. Journal Biomed. 2022;18(3):32-36. (In Russ.) https://doi.org/10.33647/2074-5982-18-3-32-36
Views:
330
Email this article 
